Several recent studies have focused on the toxicodynamic implications of amphibian exposure to the commonly used herbicide atrazine (2-chloro-4-ethylamine-6-isopropylamino-s-triazine). These studies are an important part of the risk assessment process; however, the underlying mechanisms of atrazine toxicodynamics are lacking. In an attempt to more fully describe atrazine exposure, the toxicokinetics of atrazine were studied in stage-66 Xenopus laevis larvae. The absorption, distribution, and excretion capacity of these larvae were found to be comparable to those observed in fish. The calculated bioconcentration factor (BCF) was 1.5-1.6 mLwater/glarvae, and by use of whole-body autoradiography, the radiolabel was found to be concentrated in the gall bladder and gastrointestinal tract. Elimination of atrazine was rapid with a half-life of 48 min. The high metabolic capacity of stage-66 X. laevis larvae was demonstrated where, following 8 h of exposure to 14C-atrazine, the percentages of atrazine and its metabolites deethyldeisopropylatrazine (DACT), deisopropylatrazine (DIA), and deethylatrazine (DEA) in larvae, determined by thin-layer chromatography, were 49.8% +/- 3.3%, 9.8% +/- 2.1%, 16.1% +/- 2.5%, and 15.6% +/- 2.0%, respectively. An unknown metabolite(s) was also produced and accounted for the remaining proportion of the total body radioactive residues. This metabolite(s) is hypothesized to be a conjugate of either atrazine or one of its metabolites. These metabolites, namely, DIA, were responsible for the long elimination half-life (72 h) of the total body radioactive residues. These toxicokinetics data would provide better insights in the interpretation of toxicodynamic data.
No takes yet. Share an insight, caveat, or question.
Edginton et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: